Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0W1PF
|
||||
Former ID |
DNC007133
|
||||
Drug Name |
LUF-5980
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528673] | ||
Structure |
Download2D MOL |
||||
Formula |
C21H19N3
|
||||
Canonical SMILES |
CC(C)C1=NC2=C(N1)C(=CC(=N2)C3=CC=CC=C3)C4=CC=CC=C4
|
||||
InChI |
1S/C21H19N3/c1-14(2)20-23-19-17(15-9-5-3-6-10-15)13-18(22-21(19)24-20)16-11-7-4-8-12-16/h3-14H,1-2H3,(H,22,23,24)
|
||||
InChIKey |
REXYMDQLBZWOMA-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Adenosine A3 receptor | Target Info | Inhibitor | [528673] | |
Adenosine A1 receptor | Target Info | Inhibitor | [528673] | ||
Adenosine A2b receptor | Target Info | Inhibitor | [528673] | ||
Adenosine A2a receptor | Target Info | Inhibitor | [528673] | ||
KEGG Pathway | cGMP-PKG signaling pathway | ||||
cAMP signaling pathway | |||||
Sphingolipid signaling pathway | |||||
Neuroactive ligand-receptor interaction | |||||
Morphine addictionhsa04015:Rap1 signaling pathway | |||||
Calcium signaling pathway | |||||
Vascular smooth muscle contraction | |||||
Alcoholismhsa04015:Rap1 signaling pathway | |||||
Parkinson's disease | |||||
Alcoholism | |||||
Pathway Interaction Database | C-MYB transcription factor networkhif2pathway:HIF-2-alpha transcription factor network | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.